Sales revenue of leading diabetic drugs in China 2018

The German pharmaceutical company Bayer's acarbose product Glucobay® has been the bestselling antidiabetic medication in China. It reduces glucose uptake mainly and is particularly suitable for the traditional Chinese diet high in carbohydrates. In the first nine months of 2018, the product recorded a sales revenue of nearly 395,000 yuan in the main public hospitals in China.

Sales revenue of leading antidiabetic drug brands in key public hospitals in major cities in China from January to September 2018

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2019

Region

China

Survey time period

January to September 2018

Supplementary notes

Note: 1 yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of June 2020).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Diabetes in China"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.